Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 10

Patient satisfaction and reported outcomes on the management of actinic keratosis

Authors Khanna R, Bakshi A, Amir Y, Goldenberg G

Received 2 September 2016

Accepted for publication 5 January 2017

Published 17 May 2017 Volume 2017:10 Pages 179—184

DOI https://doi.org/10.2147/CCID.S121323

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Jeffrey Weinberg


Raveena Khanna,1,2 Anshika Bakshi,3 Yasmin Amir,1 Gary Goldenberg1

1Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, 2Creighton University School of Medicine, Omaha, NE, 3Rutgers Robert Wood Johnson Medical School, Piscataway Township, NJ, USA

Abstract: Actinic keratosis (AK) is a common dermatologic condition in which hyperplastic epidermal lesions develop in response to excessive and chronic exposure to ultraviolet (UV) radiation. If left untreated, AK can progress to squamous cell carcinomas of the skin. Incidence is rising worldwide as a result of the progressive aging of populations and an increase in lifetime cumulative exposure to UV radiation. Currently, various treatment options exist, which range from topical medications to light-based therapies and procedural modalities. In this article, we will review the treatment options for AK with a focus on assessments of patient satisfaction with treatment.

Keywords: actinic keratosis, treatment, outcomes, patient satisfaction, quality of life

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]